Lisbeth Ärlestig

3.6k citations

31 papers · 721 indexed · h-index 18

Impact in

Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Immunology top 10%
- T-cell and B-cell Immunology

Papers in

Rheumatology 17
- Rheumatoid Arthritis Research and Therapies 12
- Systemic Lupus Erythematosus Research 9
Radiology, Nuclear Medicine and Imaging 20
- Monoclonal and Polyclonal Antibodies Research 20
- Radiopharmaceutical Chemistry and Applications 5

Co-authors: Solbritt Rantapää‐Dahlqvist Göran Hallmans Heidi Kokkonen Mikael Brink Alf Kastbom Martin Johansson Johan Rönnelid Leonid Padyukov
Journals: Annals of the Rheumatic Diseases (6 papers)Lara D. Veeken (3 papers)Cancer (2 papers)The Journal of Rheumatology (2 papers)Acta Oncologica (2 papers)
Partner nations: Sweden United States Italy

In The Last Decade

Lisbeth Ärlestig

27 papers receiving 713 citations

Peers

Countries citing papers authored by Lisbeth Ärlestig

Since Specialization

Citations

This map shows the geographic impact of Lisbeth Ärlestig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisbeth Ärlestig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisbeth Ärlestig more than expected).

Fields of papers citing papers by Lisbeth Ärlestig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisbeth Ärlestig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisbeth Ärlestig. The network helps show where Lisbeth Ärlestig may publish in the future.

Co-authors

The 25 scholars most cited alongside Lisbeth Ärlestig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lisbeth Ärlestig Line = papers co-authored together Lisbeth Ärlestig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pulmonary fibrosis in relation to genetic loci in an inception cohort of patients with early rheumatoid arthritis from northern Sweden Lara D. Veeken ·Michel Wagneur, Lotta Ljung, E. Norrman, Eva Freyhult, Lisbeth Ärlestig, Johanna Dahlqvist, Solbritt Rantapää‐Dahlqvist	2021	23
2	Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis Annals of the Rheumatic Diseases ·Dag Leonard, Elisabet Svenungsson, Johanna Dahlqvist, Andrei Alexsson, Lisbeth Ärlestig, Kimberly E. Taylor, Johanna K. Sandling, Christine Bengtsson, Martina Frodlund, Andreas Jönsen, Susanna Eketjäll, Kerstin Jensen‐Urstad, Iva Gunnarsson, Christopher Sjöwall, Anders Bengtsson, Maija‐Leena Eloranta, Ann‐Christine Syvänen, Solbritt Rantapää‐Dahlqvist, Lindsey A. Criswell, Lars Rönnblom	2018	32
3	Vitamin D in individuals before onset of rheumatoid arthritis - relation to vitamin D binding protein and its associated genetic variants BMC Rheumatology ·Mikael Brink, Linda Johansson, G. De Hautecoclque, Lisbeth Ärlestig, Johan Hultdin, Solbritt Rantapää‐Dahlqvist	2018	13
4	Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis Clinical Rheumatology ·Lina María Castro Cañón, Heidi Kokkonen, Lisbeth Ärlestig, Ewa Berglin, Solbritt Rantapää‐Dahlqvist	2017	21
5	Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis Arthritis Research & Therapy ·Linda Johansson, Federico Pratesi, Mikael Brink, Lisbeth Ärlestig, Claudia D’Amato, Luca Mencarelli, Paola Migliorini, Solbritt Rantapää‐Dahlqvist	2016	44
6	Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis PLoS ONE ·Izabella Surowiec, Lisbeth Ärlestig, Solbritt Rantapää‐Dahlqvist, Johan Trygg	2016	43
7	An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis Lara D. Veeken ·Xia Jiang, Henrik Källberg, M Younc, Lisbeth Ärlestig, Solbritt Rantapää‐Dahlqvist, Sonia Dávila, Lars Klareskog, Leonid Padyukov, Lars Alfredsson	2015	23
8	Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis The Journal of Rheumatology ·Alf Kastbom, Lisbeth Ärlestig, Solbritt Rantapää‐Dahlqvist	2015	28
9	B-Regulatory-, CD19(+)CD20(+) CD24(high)CD38(high) -Cells Are Functionally Impaired In Patients With Rheumatoid Arthritis and Healthy First Degree Relatives Compared With Controls Arthritis & Rheumatism ·Mikael Brink, Kristina Lejon, Lisbeth Ärlestig, Štefan Beňuš	2013	0
10	Single Nucleotide Polymorphisms within the HLA-DRB1 Gene in Relation to Antibodies Against Citrullinated Peptides in Individuals Prior to the Development of Rheumatoid Arthritis Arthritis & Rheumatism ·Lisbeth Ärlestig, Mikael Brink, Monika Hansson, Philip D’Ambrosio, Rikard Holmdahl, Linda Mathsson, Johan Rönnelid, Lars Klareskog, Štefan Beňuš	2012	0
11	Polymorphisms of the Genes EncodingCD40and Growth Differentiation Factor 15 and in the 9p21.3 Region in Patients with Rheumatoid Arthritis and Cardiovascular Disease The Journal of Rheumatology ·Lisbeth Ärlestig, Solbritt Rantapää‐Dahlqvist	2012	19
12	Genetic studies in rheumatoid arthritis : familial studies and analysis of relationships to atherothrombotic comorbidity KTH Publication Database DiVA (KTH Royal Institute of Technology) ·Lisbeth Ärlestig	2012	0
13	Influence ofFCGR3Agenotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study BMJ Open ·Alf Kastbom, L Cöster, Lisbeth Ärlestig, Katerina Chatzidionysiou, Ronald van Vollenhoven, Leonid Padyukov, Solbritt Rantapää‐Dahlqvist, Saedís Saevarsdóttir	2012	37
14	Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden Annals of the Rheumatic Diseases ·Lisbeth Ärlestig, Mohammed Mullazehi, Heidi Kokkonen, Joacim Rocklöv, Johan Rönnelid, Solbritt Rantapää‐Dahlqvist	2011	68
15	Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers Annals of the Rheumatic Diseases ·Darren Plant, Edward Flynn, Hamdi Mbarek, Philippe Dieudé, François Cornélis, Lisbeth Ärlestig, Solbritt Rantapää‐Dahlqvist, 善吉橋本, Dimitrios T. Boumpas, Prodromos Sidiropoulos, Julia S. Johansen, Lykke Midtbøll Ørnbjerg, Merete Lund Hetland, Lars Klareskog, Andrew Filer, Christopher D. Buckley, Karim Raza, T Witte, Reinhold E. Schmidt, Jane Worthington	2010	68
16	Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis Annals of the Rheumatic Diseases ·Daniel J. Dechene, Maria Seddighzadeh, Lisbeth Ärlestig, Lars Alfredsson, Solbritt Rantapää‐Dahlqvist, Leonid Padyukov	2007	30
17	PTPN22polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease Arthritis Research & Therapy ·Pankaj Rana, Lisbeth Ärlestig, Göran Hallmans, Solbritt Rantapää‐Dahlqvist	2005	82
18	Tumor necrosis factor receptor type II (exon 6) and interleukin‐6 (−174) gene polymorphisms are not associated with family history but tumor necrosis factor receptor type II is associated with hypertension in patients with rheumatoid arthritis from northern Sweden Arthritis & Rheumatism ·Solbritt Rantapää‐Dahlqvist, Lisbeth Ärlestig, Normali Abd. Ghani, Hanna Jewell	2002	21
19	Twenty Years with Monoclonal Antibodies: State of the art-Where do we go? Acta Oncologica ·Torgny Stigbrand, F. Salvat Pujo, Per Sandström, Nugroho Sulistyo Budi, Birgitta Sundström, Berith Nilsson, Lisbeth Ärlestig, Ajit Bhowmick, Katrine Riklund, S.-O. Hietala	1996	13
20	Secondary Antibodies as Tools to Improve Tumor to Non Tumor Ratio at Radioimmunolocalisation and Radioimmunotherapy Acta Oncologica ·Anders Ullén, Katrine Riklund, Lucas Rangel de Almeida Cordeiro, Rudolph Reiter, Lisbeth Ärlestig, Torgny Stigbrand	1996	8

About Lisbeth Ärlestig

Lisbeth Ärlestig is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging, Immunology, Genetics and Oncology, having authored 31 papers that have together received 721 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (20 papers), Rheumatoid Arthritis Research and Therapies (12 papers), Systemic Lupus Erythematosus Research (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers), T-cell and B-cell Immunology (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), HER2/EGFR in Cancer Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Rheumatology (424 citations), Immunology (243 citations), Radiology, Nuclear Medicine and Imaging (175 citations), Genetics (63 citations) and Hematology (59 citations). Lisbeth Ärlestig has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include Solbritt Rantapää‐Dahlqvist, Göran Hallmans, Heidi Kokkonen, Mikael Brink, Alf Kastbom, Martin Johansson, Johan Rönnelid, Leonid Padyukov, Bozena Möller and Johan Trygg. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Cancer, The Journal of Rheumatology and Acta Oncologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact